«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
11. Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-
Analysis of Randomized Controlled Trials.Kamath A, Rather ZA.Biomed Res Int.
2018 Feb 21;2018:4907264
12. Can melatonin prevent or improve metabolic side effects during antipsychotic
treatments? Porfirio, Gomes de Almeida , Stornelli , Giovinazzo , Purper-Ouakil ,
Masi Neuropsychiatr Dis Treat. 2017 Aug 10;13:2167-2174.
13. Effect of melatonin in reducing second-generation antipsychotic metabolic
effects: A double blind controlled clinical trial. Agahi M, Akasheh N, Ahmadvand A,
Akbari H, Izadpanah F. Diabetes Metab Syndr. 2018 Jan - Mar;12(1):9-15.
14. Melatonin for Reducing Weight Gain Following Administration of Atypical
Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized,
Double-Blind, Placebo-Controlled Trial. Mostafavi , Solhi M1, Mohammadi ,
Akhondzadeh. J Child Adolesc Psychopharmacol. 2017 Jun;27(5):440-444.
15. Olanzapine-induced early cardiovascular effects are mediated by the biological
clock and prevented by melatonin. Romo-Nava, Buijs , Valdés-Tovar, Benítez-King ,
Basualdo, Perusquía, Heinze, Escobar, Buijs . J Pineal Res. 2017 May;62(4).
16. Melatonin decreases olanzapine induced metabolic side-effects in adolescents
with bipolar disorder: a randomized double-blind placebo-controlled trial. Mostafavi,
Solhi , Mohammadi , Hamedi , Keshavarzi , Akhondzadeh . Acta Med Iran.
2014;52(10):734-9.
17. Melatonin attenuates antipsychotic metabolic effects: an eight-week
randomized, double-blind, parallel-group, placebo-controlled clinical trial.Romo-
Nava F1, Alvarez-Icaza González D, Fresán-Orellana A, Saracco Alvarez R,
Becerra-Palars C, Moreno J, Ontiveros Uribe MP, Berlanga C, Heinze G, Buijs RM.
Bipolar Disord. 2014 Jun;16(4):410-21.
18. Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-
psychotic side effects.Anderson , Maes M. Metab Brain Dis. 2012 Jun;27(2):113-9.
19. Protective effect of melatonin against chlorpromazine-induced liver disease in
rats. Sulaiman , Al-Shawi NN, Jwaied AH, Mahmood DM, Hussain SA. Saudi Med J.
2006 Oct;27(10):1477-82.
20.Olanzapine-induced weight gain and increased visceral adiposity is blocked by
melatonin replacement therapy in rats. Raskind M, Burke BL, Crites NJ, Tapp AM,
Neuropsychopharmacology. 2007 Feb;32(2):284-8.
21. Melatonin for the treatment of tardive dyskinesia.Nelson , McGuire JM,
Hausafus SN. Ann Pharmacother. 2003 Jul-Aug;37(7-8):1128-31.
22. The role of melatonin in the antipsychotic and motor-side effects of neuroleptics:
a hypothesis.Sandyk R, Kay SR, Gillman MA. Int J Neurosci. 1992 May-Jun;64(1-
4):203-7.
23. Antipsychotics and glucose metabolism: how brain and body collide Chantel
Kowalchuk, Laura Castellani, Araba Chintoh, Gary Remington, Adria Giacca, and
Margaret Hahn JUL 2018